Medicare Advantage rates for 2027 have been finalized, with reports indicating a higher rate than initially proposed. However, there is some uncertainty as the White House had proposed nearly flat rates, and some outlets suggest the finalized rates may not be as favorable to insurers as initially thought. The decision has had an impact on insurer stocks, with some reports noting an increase in stock value for companies such as UnitedHealth.